
Chorizo and cheese off menu for returning British holidaymakers
Tourists have been banned from bringing cured meats and cheeses from Europe back to Britain as cases of foot-and-mouth disease rise on the Continent.
The Government has enacted a clampdown on so-called 'personal imports' of meat, dairy and other products from Europe after a surge in cases of the disease among livestock.
Travellers hoping to bring back delicacies such as Spanish chorizo or Italian pecorino and gorgonzola cheeses now risk having their goods seized and destroyed. Some could face fines of up to £5,000 if they are caught trying to bring them through an airport, the Government said.
Officials do not collect data on the quantities of food and drink brought into the UK through airports every year. However, the UK imports around 2.2m kilos of authentic chorizo commercially each year, suggesting products like this are likely to be popular with tourists.
The ban is indefinite and will go on until ministers deem there is no longer a significant risk to the UK. Daniel Zeichner, the farming minister, said: 'This Government will do whatever it takes to protect British farmers from foot-and-mouth.'
Cases of the disease, which affects cows and pigs, were reported in Germany, Hungary and Slovakia earlier this year.
Commercial imports of pigs, cattle and sheep from those countries have already been restricted, although a ban on German imports was lifted in March after Berlin enacted a containment zone around the area where cases were found.
Jorge Martin-Almagro, the UK deputy chief veterinary officer for international and trade affairs, said: 'Robust contingency plans are already in place to manage the risk of this disease to protect farmers and Britain's food security.
'This biosecurity measure combined with all others we have implemented are critical to limit the risk of [foot-and-mouth] incursion.'
Because of the severity of its impact, foot-and-mouth is a legally notifiable disease, which means it is an offence not to report it to the Government.
The disease does not affect humans, but is highly infectious in livestock, causing fever and blisters in the mouth and on their hooves. It is not usually fatal but has a higher mortality rate among younger animals.
Previous outbreaks have devastated livestock farms and hammered Britain's rural economy, such as in 2001 and 2007, when millions of cows, pigs and sheep had to be culled, costing the public sector and private companies billions.
In a statement earlier this year, Mr Zeichner said Britain's livestock farmers should 'be absolutely rigorous about their biosecurity' given the emergence of cases in Europe.
Ministers last year announced plans to plough £200m into the country's main animal and plant research and testing facility in Weybridge, Surrey, in the hopes of boosting Britain's defences against the disease and preventing future incidents.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
2 hours ago
- Daily Mirror
New ‘Star Wars' cancer treatment which pulverises tumours with sound waves
The NHS is set to become the only health system in Europe to use ground-breaking histotripsy technology, which removes the need for surgery by firing pulses to form micro bubbles from gases A 'Star Wars' treatment which zaps hard-to-reach cancers using sound waves is being trialled on the NHS. The technology, called histotripsy, removes the need for surgery and instead fires pulses to form micro bubbles from gases within the tumour. These 'bubble clouds' expand and contract in microseconds to destroy the cancer cells. The targeted ultrasound technology currently only available in the US will now be trialled by the NHS on liver cancer patients in Cambridge. If successful regulators say it will be a 'a major step forward' which it is hoped could be used to destroy pancreatic and kidney cancers. The Government says Health Secretary Wes Streeting intervened to authorise controlled early access to the device, as part of a new Innovative Devices Access Pathway (ADIP) programme. Mr Streeting, who previously had kidney cancer, told the Mirror: 'I've slashed red tape, so NHS patients will be the first in Europe to benefit from a revolutionary and non-invasive liver cancer treatment – that uses ultrasound technology to destroy tumours - years earlier than planned. "Patients stand to see faster recovery times, fewer dangerous complications, and shorter hospital stays. We are slashing red tape, so game-changing new treatments reach the NHS front line quicker.' In contrast to invasive surgery, the targeted ultrasound can take just 30 minutes with 'limited or no pain' and involves a quick recovery. It destroys tissue at cellular and sub-cellular levels while avoiding the ionising damage of radiation or the heat damage from thermal treatments. The bubble clouds cause the cancerous mass to break apart, destroying tumor cells and leaving the debris to be eliminated by the immune system. US cancer expert Dr Jennifer Linehan, of St John's Cancer Institute, said the device could in future also be used to pulverise prostate and bladder cancers. She said: 'This technology kills tumours without even touching you. Sometimes when I'm talking to patients I tell them this is ' Star Wars technology' because there are no cuts, there's no poking, there's nothing that's going inside you from outside. It's all happening with a focused beam of ultrasound to destroy the tumours.' The first cancer patients in Europe to access the treatment under such a scheme will be treated for their liver cancer at Addenbrooke's Hospital in Cambridge this summer. The machine, manufactured by HistoSonics, is expected to be fully installed later this year, where it will be used initially to treat patients with primary and secondary liver tumours. Wider research on how this could potentially treat tumours in other organs is underway. James Pound, innovation director at the Medicines and Healthcare products Regulatory Agency (MHRA), said: 'We've shown we can get promising technologies to patients faster without compromising safety. It's a major step forward for patients with liver cancer and shows how the UK can be a frontrunner in supporting responsible innovation that meets real clinical need.' Patients undergoing histotripsy are given general anesthesia to control breathing and to minimize movements of targeted tumours An evaluation of the NHS pilot will be published later this year by the Department of Health and Social Care. Histotripsy has already been approved to treat liver tumors by the US Food and Drug Administration (FDA). Roland Sinker, Chief Executive of Cambridge University Hospitals said: 'Histotripsy is an exciting new technology that will make a huge difference to patients. By offering this non-invasive, more targeted treatment we can care for more people as outpatients and free up time for surgeons to treat more complex cases. 'The faster recovery times mean patients will be able to return to their normal lives more quickly, which will also reduce pressure on hospital beds, helping us ensure that patients are able to receive the right treatment at the right time.' Wes Streeting - Secretary of State for Health and Social Care As a cancer survivor, I know what an incredible impact medical technology can have. After I was diagnosed with kidney cancer, I was treated by a world-class surgeon equipped with a robot. Together, they saved my life. The NHS is abuzz with innovation and creativity. We're already witnessing the trial of an AI-driven blood test to spot common cancers, the roll-out of a game-changing system to bring cancer patients' data together, and the unprecedented expansion of the NHS app. It is my job to put the wind in the sails and give the world's greatest minds the freedom to unleash tomorrow's tech. To strengthen Britain's role as a global leader, those innovators must be freed from the shackles of stifling regulatory processes. Of course, we need to keep patients safe, but technology is moving quickly, and so must we. That's why I've already slashed red tape, so NHS patients will be the first in Europe to benefit from a revolutionary and non-invasive liver cancer treatment – developed by US-based company HistoSonics – that uses ultrasound technology to destroy tumours, years earlier than planned. Patients stand to see faster recovery times, fewer dangerous complications, and shorter hospital stays. Soon, we will publish the 10 Year Health Plan – a once in a generation strategy to save and rebuild the NHS, delivering a health service fit for the future. This government will unleash innovation to speed the shift from analogue to digital, and tackle the bureaucracy holding back our public services No longer will the creativity needed to bring our NHS into the modern age be stifled. Through our Plan for Change, we will get the latest tech to our NHS frontline, put patients first and develop a 21st century health service that's, once again, the envy of the world.

Rhyl Journal
13 hours ago
- Rhyl Journal
LTA to support British women's tennis players' health
The initiative will offer bespoke support around education, nutrition and research as well as medical screening to optimise their performance and well-being. The programme has been designed to address specific challenges female athletes face, offering targeted interventions and expert guidance, led by LTA Chief Medical Officer Dr Guy Evans. Examples include offering medical screenings to all professional players supported via the LTA Player Pathway. These screenings are tailored around female health and menstrual cycles, and gives the athletes access to specialised medical support tailored to their physical reproductive health needs. A podcast series has been launched featuring discussions with leading experts to highlight and educate critical female health issues that impact elite athletes. DEXA scanning (Dual-Energy X-ray Absorptiometry) has been introduced to assess bone mineral density, providing vital data on injury prevention and energy balance (Image: LTA) Pioneering research into understanding and mitigating health risks for female athletes has also been announced as well as a Pregnancy and Maternity Policy – the first of its kind in British tennis – to support players through pregnancy and postpartum recovery. LTA National Coach and former British No.1 Katie O'Brien said: 'The sporting health of our athletes is significantly important to us since this is awareness of female health has been growing massively in recent years since I was a player. 'We would like to thank Dr. Guy Evans for his leadership in driving work forward so we are able to support our British female players the best that we can and help them achieve their best performance.' In late 2024, the LTA launched a Breast Health and Bra Fitting Service for female players, highlighting the importance of wearing a correctly fitted sports bra for both performance and breast health. For the past two years, the LTA has hosted the UK Sports Gynaecology Conference at the National Tennis Centre, bringing together chief medical officers, gynaecological surgeons, and sports science experts to discuss and advance female athlete health. The 2025 event saw over 50 industry leaders gather in Roehampton, tackling issues such as low energy availability, gender-specific concerns in sport, and effective medical strategies for female athletes. Dr Evans added: 'These conferences provide a dedicated forum to discuss the care of elite female athletes across sports and disciplines. It allows sharing of knowledge, open discussion and healthy debate ensuring we provide optimal care for our female athletes. The conferences shine a light on some of the key topical issues such as low energy availability, sex and gender related issues in sport, and effective strategic planning related to the female athlete with the sporting setting.' Through these innovative and tailored initiatives, the LTA is setting new standards for female athlete health and support in tennis. By addressing medical needs, providing essential education, prioritising nutrition, and driving research, the LTA is empowering female athletes to thrive both on and off the court.


Glasgow Times
14 hours ago
- Glasgow Times
John Swinney visits GP in Glasgow's Easterhouse for project
Oakwood Medical Practice in Easterhouse is one of 12 deprived areas across Glasgow taking part in the Whole Family Support in General Practice project, which takes a preventative approach to family wellbeing. It uses GP appointments to identify wider support needed to help families in poverty and at risk of poor health outcomes. READ MORE: 'Completely unacceptable': John Swinney condemns unofficial Celtic title party The First Minister will visit today, and hailed the 'collaborative, preventative work' which has received a combined £3.5 million from the Scottish Government since 2023. Each of the practices has a family wellbeing worker who can provide advice on the right kinds of support and the partner service best placed to help. The project also supports outreach work with families who might benefit from further engagement with primary care services to address complex health needs. The three-year project is led by Glasgow City Health and Social Care Partnership, supported by more than £1.5 million in Scottish Government funding for 2025-26. READ MORE: Gangland violence 'out of control' John Swinney is told after Spain shootings READ MORE: 'We never gave up': Family's heartbreaking tribute as body of missing teen found Speaking ahead of the visit, he said: 'Scotland's GP practices are right at the heart of our communities where they help local people and their families on a daily basis. We recognise them as trusted and established services providing crucial medical advice and care. 'It is precisely this trust that means GP surgeries can be places where people start to get a wider variety of help that will allow them to overcome the challenges of everyday life, tackle poverty and address further risks to their health and wellbeing. 'Eradicating child poverty and improving public services are two of my main priorities as First Minister. Along with economic growth and tackling the climate emergency, they are the key areas where I want to see delivery of real improvements. 'I've spoken often about how these priorities don't exist in isolation – there will be lots of different connections between them. 'The Whole Family Support In General Practice project is exactly the sort of work I had in mind – collaborative, preventative work that will deliver clear benefits for people in Scotland.'